P. Kumar Rao, MD

Associate Professor, Ophthalmology and Visual Sciences

Patients Seen At: (314) 273-0020 (Eye Center in South County, 13303 Tesson Ferry Road, Suite 100)
(314) 362-EYES (Eye Center, Center for Advanced Medicine, 4921 Parkview Place, Suite C, 12th Floor)

Fax: (314) 842-2316 (Eye Center in South County, 13303 Tesson Ferry Road, Suite 100)
(314) 362-3725 (Eye Center, Center for Advanced Medicine, 4921 Parkview Place, Suite C, 12th Floor)

Email: RaoP@vision.wustl.edu

Education

  • M.D., University of Southern California, Los Angeles, California, 2005

Training

  • Internship: St. Luke’s Medical Center Milwaukee, Wisconsin, 1995 - 1996
  • Residency: Ophthalmology – Medical College of Wisconsin, Milwaukee, Wisconsin, 1996 - 1999
  • Fellowship: Vitreoretinal Diseases – Barnes Retina Institute/Washington University of Medicine, St. Louis, Missouri, 1999 - 2001
  • Fellowship: Ophthalmic Pathology – Washington University School of Medicine, St. Louis, Missouri, 2001 - 2002

Licensure and Board Certification

  • Diploma – American Board of Ophthalmology, 2001
  • Maintenance of Certification – Recertified, 2012

Honors and Awards

  • Revelle Leadership Award - University of California, San Diego, California, 1990
  • Jack C. Copland Memorial Award for Resident Research - Medical College of Wisconsin, Milwaukee, Wisconsin, 1999
  • Ophthalmology Teacher of the Year, Academic Faculty - Washington University School of Medicine, St. Louis, Missouri, 2003
  • Academic Keys Who’s Who in Medicine Higher Education, 2008
  • Ophthalmology Teacher of the Year, Academic Faculty - Washington University School of Medicine, St. Louis, Missouri, 2011
  • AAO Achievement Award, 2012
  • Missouri Society of Eye Physicians and Surgeons – President’s Award, 2014

Selected Publications

  1. Aaberg TA, Cook RW, Oelschlager K, Maetzold D, Rao PK, Mason JO. Current Clinical Practice: Differential Management of Uveal Melanoma in the Era of Molecular Tumor Analyses. Clinical Ophthalmology 2014:8 2449-2460. December 3,2014
  2. Abuattieh MO, Rao PK, Apte RS. Efficacy of Afilbercept in Bevacizumab Treated But Persistently Active Neovascular AMD. Retina; Submitted May 2014.
  3. Earl JB, Lee CS, Yom V, Van Stavern GP, Abuattieh MO, Chin Yee D, Rao PK, Apte RS. Visual Cycle Suppression Via Patching in Central Serous Chorioretinopathy. Ophthalmology 2014 Dec; 121(12):2502-2504 [DOI:10.1016/j.ophthal.2014.06.038]
  4. Khan M, Rao RC, Rao PK. Shimering Lights. JAMA Ophthalmology 2014;132(8):1015-1016
  5. Sheybani A, Harocopos GJ, Rao PK, Immunohistochemical Study of Epiretinal Membranes in Patients with Uveitis: Case Discussion. J. Ophthalmol Inflamm Infect 2012; 2(4):243-48 [DOI: 10.1077/s12348-012-0744-x]
  6. Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard KD. Birle A, Srivastava SK, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm 2012; 20(2):104-12 [PMID:22409563]
  7. CATT Research Group, Martin DF, Maguire Mg, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med 2011; 364(20):1897-908 [PMID21526923] [PMCID:PMC3157322]
  8. Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH, for the MUST Trial Research Group. Morphologic Assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocular Immunol Inflamm 2011; 19(4):267-74 [PMID:21770805]
  9. Kraus CL, Rao PK, Apte RS. Effect of Preoperative Vitreous Status on Visual Outcomes Following Vitrectomy for Epiretinal Membrane Repair. Can J Ophthalmol 2011; 46(2):186-90 [PMID:21708089]
  10. Ramaiya KJ, Rao PK. Herpetic Necrotizing Retinitis following Fluocinolone Acetonide Intravitreal Implant. Ocul Immunol Inflamm 2011; 19(1):72-4 [PMID:21034309]
  11. Multicenter Uveitis Steroid Treatment Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics. AM J Ophthalmol 2010; 149(4):550-61 [PMID:20097325] [PMCID:PMC2975449]
  12. Vasconcelos-Santos DV, Rao PK, Davies JB, MD, Sohn EH, Rao NA. Clinical Features of Presumed Tuberculous Serpiginous-Like Choroiditis in Contrast to Classic Serpiginous Choroiditis. Arch Ophthalmol 2010; 128(7):853-8 [PMID:20625045]

Internal Links

DOVS Portal

Follow Us: